English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer.

Coscia, F., Lengyel, E., Duraiswamy, J., Ashcroft, B., Bassani-Sternberg, M., Wierer, M., et al. (2018). Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer. Clinical Cancer Research, 24(15), 95-95.

Item is

Basic

show hide
Genre: Meeting Abstract

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Coscia, Fabian1, Author              
Lengyel, Ernst2, Author
Duraiswamy, Jaikumar2, Author
Ashcroft, Bradley2, Author
Bassani-Sternberg, Michal1, Author              
Wierer, Michael1, Author              
Johnson, Alyssa2, Author
Wroblewski, Kristen2, Author
Montag, Anthony2, Author
Yamada, S. Diane2, Author
Mann, Matthias1, Author              
Curtis, Marion2, Author
Affiliations:
1Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565159              
2external, ou_persistent22              

Content

show
hide
Free keywords: Oncology;
 Abstract: -

Details

show
hide
Language(s): eng - English
 Dates: 2018
 Publication Status: Published in print
 Pages: 1
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: ISI: 000440823600129
 Degree: -

Event

show
hide
Title: AACR Special Conference on Addressing Critical Questions in Ovarian Cancer Research and Treatment
Place of Event: Pittsburgh, PA
Start-/End Date: 2017-10-01 - 2017-10-04

Legal Case

show

Project information

show

Source 1

show
hide
Title: Clinical Cancer Research
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Denville, NJ : Association for Cancer Research
Pages: - Volume / Issue: 24 (15) Sequence Number: - Start / End Page: 95 - 95 Identifier: ISSN: 1078-0432
CoNE: https://pure.mpg.de/cone/journals/resource/954925605818